Algernon Pharmaceuticals Eulerpool News

Algernon Pharmaceuticals Eulerpool News

Algernon Pharmaceuticals Notizie Azioni

Algernon Pharmaceuticals è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Algernon Pharmaceuticals.

• 21 maggio ·

  Yahoo
  Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
• 24 aprile ·

  Yahoo
  Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
• 11 aprile ·

  Yahoo
  Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
• 1 aprile ·

  Yahoo
  Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
• 28 marzo ·

  Yahoo
  Algernon Pharmaceuticals Strikes Deal to Advance Ifenprodil in Chronic Cough Treatment
• 27 marzo ·

  Yahoo
  Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
• 31 gennaio ·

  Yahoo
  Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
• 11 gennaio ·

  Yahoo
  Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
• 27 dicembre ·

  Yahoo
  Algernon Pharmaceuticals Announces Closing of Private Placement
• 27 dicembre ·

  Yahoo
  Algernon Pharmaceuticals Announces Increase to Private Placement